Articles by Disease (Intracranial Hypotension)

Ziconotide: Neuronal Calcium Channel Blocker for Treating Severe Chronic Pain

Journal: Current Medicinal Chemistry
Volume: 11
Page: 3029-3040
Author(s): G. P. Miljanich

Magnesium as a Neuroprotective Agent in Cerebral Ischemia

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 4
Page: 215-222
Author(s): C.C. Ionita, J.F. Kirmani, A.R. Xavier and A.I. Qureshi

α-Fibrinogenases

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 4
Page: 417-435
Author(s): S. Swenson, C. F. Toombs, L. Pena, J. Johansson and F. S. Markland Jr.

Propofol: Therapeutic Indications and Side-Effects

Journal: Current Pharmaceutical Design
Volume: 10
Page: 3639-3649
Author(s): Paul E. Marik

Involvement of the Endogenous Opioid System in Cannabinoid Responses

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 4
Page: 183-193
Author(s): Olga Valverde, Patricia Robledo and Rafael Maldonado

Molecular and Cellular Mechanisms in the Pathophysiology of Severe Head Injury

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2131-2143
Author(s): Enriquez P and Bullock R.

Arterial Hyperoxia in Severe Head Injury: A Useful or Harmful Option?

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2163-2176
Author(s): O. L. Alves, W. P. Daugherty and M. Rios

Cannabinoids as Neuroprotective Agents in Traumatic Brain Injury

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2177-2183
Author(s): Anat Biegon

Endothelins and the Role of Endothelin Antagonists in the Management of Posttraumatic Vasospasm

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2185-2192
Author(s): W. M. Armstead

Moderate Hypothermia in the Management of Severe Traumatic Brain Injury: A Good Idea Proved Ineffective?

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2193-2204
Author(s): J. Sahuquillo, M. P. Mena, A. Vilalta and M. A. Poca